Renovaro Inc.

NASDAQ:RENB   4:00:00 PM EDT
0.66
+0.03 (+5.51%)
5:06:51 PM EDT: $0.66 +0.01 (+0.76%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Renovaro Inc. Stock, NASDAQ:RENB

1927 Paseo Rancho Castillo, Suite 906, Los Angeles, California 90032-2012
United States of America
Phone: +1.305.918.1980
Number of Employees: 12
http://renovarobio.com

Description

Renovaro, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Los Angeles, CA.